COR | CencoraNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$337.84
+$7.00 (+2.12%)

Cencora (COR) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
above both $337.84 vs 50 $323.77 / 200 $317.00
Projection
No cross projected
Test
No active test
Last cross
Golden cross 7 Oct 2026 ยท projected 7 bars out ยท tested 3 bars

Weekly as of 30 Oct 16:00 ET

Price
above both $330.84 vs 50 $322.32 / 200 $248.95
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 16:00 ET

Price
above both $340.50 vs 50 $327.93 / 200 $313.70
Projection
No cross projected
Test
No active test
Last cross
No cross on record

Cross history

12
crosses on record since 2018
6 golden6 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
7 Oct 2026Golden flatdaily7 bars out3 bar cross test
7 May 2026Death steepdaily29 bars outNot tested
26 Nov 2024Goldendaily28 bars outNot tested
30 Oct 2024Deathdaily23 bars out2 bar cross test
10 Jun 2021Goldendaily12 bars outNot tested

About COR

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$363M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.